Details for New Drug Application (NDA): 021835
✉ Email this page to a colleague
The generic ingredient in CLOBEX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 021835
Tradename: | CLOBEX |
Applicant: | Galderma Labs Lp |
Ingredient: | clobetasol propionate |
Patents: | 0 |
Pharmacology for NDA: 021835
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 021835
Suppliers and Packaging for NDA: 021835
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835 | NDA | Galderma Laboratories, L.P. | 0299-3849 | 0299-3849-01 | 1 BOTTLE in 1 CARTON (0299-3849-01) / 10 mL in 1 BOTTLE |
CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835 | NDA | Galderma Laboratories, L.P. | 0299-3849 | 0299-3849-02 | 1 BOTTLE in 1 CARTON (0299-3849-02) / 59 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY;TOPICAL | Strength | 0.05% | ||||
Approval Date: | Oct 27, 2005 | TE: | AT | RLD: | Yes |
Expired US Patents for NDA 021835
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galderma Labs Lp | CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835-001 | Oct 27, 2005 | 5,972,920 | ⤷ Subscribe |
Galderma Labs Lp | CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835-001 | Oct 27, 2005 | 5,990,100 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription